TRIPAWDS: Home to 14597 Members and 1246 Blogs.
HOME » NEWS » BLOGS » FORUMS » CHAT » FACEBOOK » TWITTER » RANDOM BLOG

University of Missouri Clinical Trial: Canine Cachexia Study | Tips and Resources

JUMP TO FORUMS

Join The Discussion

Learn about life on three legs in the forums below. Browse and search as a guest or register for free to take advantage of member benefits:

  • Instant post approval.
  • Private messages to members.
  • Subscribe to favorite topics.
  • Join the Live Chat and more!

free tripawds account tripawds member log in

K9 Immunity Plus — Hope For Dogs With Cancer

Get help with Dr. Dressler's Dog Cancer Kit

Best Dog Beds for Tripawds

ruffwear urban sprawl dog bed

Give Tripawds the comfort they deserve! See which dog beds are best and why.

» Recent Blog Posts

Stay tuned for more recent posts.




A A A

Please consider registering
Guest

Search

— Forum Scope —




— Match —





— Forum Options —





Minimum search word length is 3 characters - maximum search word length is 84 characters

Register Lost password?
sp_Feed sp_PrintTopic sp_TopicIcon-c
University of Missouri Clinical Trial: Canine Cachexia Study
sp_NewPost Add Reply sp_NewTopic Add Topic
The Rainbow Bridge

Forum Posts: 22458
Member Since:
25 April 2007
sp_UserOfflineSmall Offline
1
18 April 2017 - 12:12 pm
sp_Permalink sp_Print sp_NewPost sp_QuotePost

Mizzou seeks canine cancer patients for clinical trials

The University of Missouri’s Veterinary Health Center is seeking cancer-stricken canines to test a drug researchers hope will let dogs — and maybe someday humans — live longer.

The university is running clinical trials in partnership with Tensive Controls Inc. on a medication for cachexia, a wasting syndrome that causes about one-third of cancer deaths.

Cachexia occurs with advanced cancers, causes loss of appetite and can lead to multiorgan failure.

Read more here: http://www.kans.....rylink=cpy

For a direct link to the Mizzou website page about the trial, see Current Clinical Trials. Here's a description of the study:

Canine Cachexia Clinical Trial

The true prevalence of cachexia in canine patients has not been determined, due in part to euthanasia when a pet’s quality of life declines and weight loss ensues. The objectives for this study are to determine toxicity, including cardiovascular effects of the final drug candidate of MC4 peptide receptor antagonist and to determine preliminary efficacy of MC4 peptide receptor antagonist in dogs with cachexia.

Criteria:

  • History of 5% or greater with loss within past three months
  • Radiation and chemotherapy allowed at clinician discretion
  • Washout of 2 days required for appetite stimulants.
  • CBC, chemistry panel, UA, and abdominal ultrasound within 14 days of enrollment
  • Corticosteriod use allowed if > 14 days prior to enrollment

It's better to hop on three legs than to limp on four.™
Latest Tripawds News
Read my story here.

Support the Tripawds Foundation!

Forum Timezone: America/Denver

Most Users Ever Online: 597

Currently Online:
58 Guest(s)

Currently Browsing this Page:
1 Guest(s)

Devices Used: Desktop (47), Phone (11)

Member Stats:

Guest Posters: 973

Members: 10987

Moderators: 2

Admins: 3

Forum Stats:

Groups: 4

Forums: 23

Topics: 14075

Posts: 195892

Administrators: jerry, admin, jim

Moderators: betaman, krun15

Tripawds Blogs is brought to you by Tripawds.
HOME » NEWS » BLOGS » FORUMS » CHAT » FACEBOOK » TWITTER » RANDOM BLOG